PATENT CLAIM ANALYSIS

Application Number: 16200478
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "018600"]

Abstract:
C-terminal endostatin polypeptides are disclosed herein. Polynucleotides encoding these polypeptide, host cells transformed with the polynucleotides, and methods of using these polypeptides and polynucleotides are disclosed. Uses of these polypeptide, polynucleotides and expression vectors include the treatment of fibrosis in a subject. Thus, methods are provided for treating fibrosis, including fibrosis of the skin and/or the lung.

Claim (Index 14):
The composition of  claim 9 , comprising a therapeutically effective amount of the polypeptide.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 98.0
- Lexical Diversity: 1.69231
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13939058', '13503339', '14207246', '15152468', '15385705']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8458000809714545
- 35 USC 102 Novelty (BERT): 0.6002355738060247
- Combined Prediction Score: 0.8212436302549116
- Mean Citation Score: 623.6017400000002
- Max Citation Score: 645.53735
- Similarity Product: 424.55910446708793

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test